ZNF474 抗体 (Middle Region)
(1 reference)Our Local Distributor
北京 101111
Quick Overview for ZNF474 抗体 (Middle Region) (ABIN2777355)
抗原
适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- Middle Region
-
原理
- ZNF474 Antibody - middle region
-
序列
- NDRLPVELHQ PLPQKPQPLP NAQSSQAGPN QAQLVFCPHC SRIFTSDRLL
-
预测反应
- Human: 100%, Mouse: 85%, Rat: 77%
-
产品特性
- This is a rabbit polyclonal antibody against ZNF474. It was validated on Western Blot using a cell lysate as a positive control.
-
纯化方法
- Affinity Purified
-
免疫原
- The immunogen is a synthetic peptide directed towards the middle region of human ZNF474
-
-
anti-Zinc Finger Protein 474 (ZNF474) (AA 251-300) antibody
ZNF474 适用: 人, 小鼠, 大鼠 WB 宿主: 兔 Polyclonal unconjugated
anti-Zinc Finger Protein 474 (ZNF474) (AA 35-84) antibodyZNF474 适用: 人, 猴 WB 宿主: 兔 Polyclonal unconjugated
anti-Zinc Finger Protein 474 (ZNF474) (Middle Region) antibodyZNF474 适用: 人, 小鼠, 大鼠 WB 宿主: 兔 Polyclonal unconjugated
anti-Zinc Finger Protein 474 (ZNF474) (N-Term) antibodyZNF474 适用: 人, 小鼠, 大鼠, Cow WB 宿主: 兔 Polyclonal unconjugated
anti-Zinc Finger Protein 474 (ZNF474) (N-Term) antibodyZNF474 适用: 人, 小鼠, 大鼠, Cow, 犬, 马, Pig WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
说明
-
We also sell a specific blocking peptide that can be used in combination with this antibody. You can find the blocking peptide under AAP31557-100UG
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.5 mg/mL
-
缓冲液
- Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- prevent freeze-thaw cycles
-
储存条件
- 4 °C,-20 °C
-
储存方法
- For short term use, store at 2-8C up to 1 week. For long term storage, store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
-
-
: "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). ..." in: Genome research, Vol. 14, Issue 10B, pp. 2121-7, (2004) (PubMed).
-
-
-
